(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC22A23 mRNA] CTD PMID:31150632 1,1'-diethyl-2,2'-cyanine multiple interactions ISO RGD:1347503 6480464 pseudoisocyanine inhibits the reaction [SLC22A23 protein results in increased uptake of 1-Methyl-4-phenylpyridinium analog] CTD PMID:28597291 1,1-dichloroethene decreases expression ISO RGD:1621497 6480464 vinylidene chloride results in decreased expression of SLC22A23 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:1621497 6480464 1, 2-Dimethylhydrazine results in decreased expression of SLC22A23 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1621497 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC22A23 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of SLC22A23 mRNA CTD PMID:25380136 17beta-estradiol multiple interactions ISO RGD:1347503 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC22A23 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC22A23 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1621497 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC22A23 mRNA CTD PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC22A23 mRNA CTD PMID:21215274 , PMID:32109520 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of SLC22A23 mRNA CTD PMID:28522335 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of SLC22A23 protein CTD PMID:34915118 3-methylcholanthrene multiple interactions ISO RGD:1347503 6480464 Methylcholanthrene promotes the reaction [AHR protein binds to SLC22A23 promoter] CTD PMID:20348232 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of SLC22A23 mRNA CTD PMID:25380136 4-hydroxyphenyl retinamide decreases expression ISO RGD:1621497 6480464 Fenretinide results in decreased expression of SLC22A23 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SLC22A23 mRNA CTD PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLC22A23 mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of SLC22A23 mRNA CTD PMID:28959563 aflatoxin B1 decreases methylation ISO RGD:1347503 6480464 Aflatoxin B1 results in decreased methylation of SLC22A23 gene CTD PMID:27153756 aflatoxin B1 affects methylation ISO RGD:1347503 6480464 Aflatoxin B1 affects the methylation of SLC22A23 intron CTD PMID:30157460 Aflatoxin B2 alpha affects methylation ISO RGD:1347503 6480464 aflatoxin B2 affects the methylation of SLC22A23 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1347503 6480464 Tretinoin results in increased expression of SLC22A23 mRNA CTD PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC22A23 mRNA CTD PMID:16483693 aristolochic acid A increases expression ISO RGD:1347503 6480464 aristolochic acid I results in increased expression of SLC22A23 mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:1347503 6480464 Arsenic affects the methylation of SLC22A23 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1347503 6480464 Arsenic affects the methylation of SLC22A23 gene CTD PMID:25304211 Benoxacor increases expression ISO RGD:1621497 6480464 benoxacor results in increased expression of SLC22A23 mRNA CTD PMID:34850242 benzo[a]pyrene decreases expression ISO RGD:1347503 6480464 Benzo(a)pyrene results in decreased expression of SLC22A23 mRNA CTD PMID:20064835 more ... benzo[a]pyrene affects methylation ISO RGD:1347503 6480464 Benzo(a)pyrene affects the methylation of SLC22A23 intron CTD PMID:30157460 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1347503 6480464 7 more ... CTD PMID:26238291 benzo[e]pyrene increases methylation ISO RGD:1347503 6480464 benzo(e)pyrene results in increased methylation of SLC22A23 intron CTD PMID:30157460 Benzo[k]fluoranthene decreases expression ISO RGD:1621497 6480464 benzo(k)fluoranthene results in decreased expression of SLC22A23 mRNA CTD PMID:26377693 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC22A23 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1621497 6480464 bisphenol A results in increased expression of SLC22A23 mRNA CTD PMID:34585602 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC22A23 mRNA CTD PMID:30816183 more ... butan-1-ol multiple interactions ISO RGD:1347503 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SLC22A23 mRNA CTD PMID:29432896 butanal decreases expression ISO RGD:1347503 6480464 butyraldehyde results in decreased expression of SLC22A23 mRNA CTD PMID:26079696 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of SLC22A23 promoter CTD PMID:22457795 calcitriol increases expression ISO RGD:1347503 6480464 Calcitriol results in increased expression of SLC22A23 mRNA CTD PMID:16002434 carbon nanotube decreases expression ISO RGD:1621497 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of SLC22A23 mRNA CTD PMID:18500788 cisplatin decreases expression ISO RGD:1347503 6480464 Cisplatin results in decreased expression of SLC22A23 mRNA CTD PMID:27392435 copper(II) sulfate decreases expression ISO RGD:1347503 6480464 Copper Sulfate results in decreased expression of SLC22A23 mRNA CTD PMID:19549813 coumestrol decreases expression ISO RGD:1347503 6480464 Coumestrol results in decreased expression of SLC22A23 mRNA CTD PMID:19167446 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of SLC22A23 mRNA CTD PMID:27523638 cyclosporin A increases methylation ISO RGD:1347503 6480464 Cyclosporine results in increased methylation of SLC22A23 promoter CTD PMID:27989131 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of SLC22A23 mRNA CTD PMID:21266533 dieldrin decreases expression EXP 6480464 Dieldrin results in decreased expression of SLC22A23 mRNA CTD PMID:23153324 dioxygen multiple interactions ISO RGD:1621497 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC22A23 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:1347503 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC22A23 mRNA CTD PMID:27188386 ethanol affects expression ISO RGD:1621497 6480464 Ethanol affects the expression of SLC22A23 mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:1621497 6480464 Ethanol results in increased expression of SLC22A23 mRNA CTD PMID:30319688 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of SLC22A23 mRNA CTD PMID:30307764 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of SLC22A23 mRNA CTD PMID:34044035 fluoranthene multiple interactions ISO RGD:1621497 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC22A23 mRNA CTD PMID:28329830 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SLC22A23 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1621497 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC22A23 mRNA CTD PMID:22206623 formaldehyde decreases expression ISO RGD:1347503 6480464 Formaldehyde results in decreased expression of SLC22A23 mRNA CTD PMID:27905399 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC22A23 mRNA CTD PMID:33387578 glyphosate affects expression EXP 6480464 glyphosate affects the expression of SLC22A23 mRNA CTD PMID:26302742 lipopolysaccharide increases expression ISO RGD:1347503 6480464 Lipopolysaccharides results in increased expression of SLC22A23 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:1347503 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of SLC22A23 mRNA] CTD PMID:35811015 menadione affects expression ISO RGD:1347503 6480464 Vitamin K 3 affects the expression of SLC22A23 mRNA CTD PMID:20044591 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of SLC22A23 mRNA CTD PMID:30467583 methapyrilene increases methylation ISO RGD:1347503 6480464 Methapyrilene results in increased methylation of SLC22A23 intron CTD PMID:30157460 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:1347503 6480464 pseudoisocyanine inhibits the reaction [SLC22A23 protein results in increased uptake of 1-Methyl-4-phenylpyridinium analog], Sulpiride inhibits the reaction [SLC22A23 protein results in increased uptake of 1-Methyl-4-phenylpyridinium analog] CTD PMID:28597291 N-methyl-4-phenylpyridinium increases uptake ISO RGD:1347503 6480464 SLC22A23 protein results in increased uptake of 1-Methyl-4-phenylpyridinium analog CTD PMID:28597291 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of SLC22A23 mRNA CTD PMID:25380136 nickel sulfate increases expression ISO RGD:1347503 6480464 nickel sulfate results in increased expression of SLC22A23 mRNA CTD PMID:22714537 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC22A23 mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:1621497 6480464 Acetaminophen affects the expression of SLC22A23 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC22A23 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1347503 6480464 Acetaminophen results in decreased expression of SLC22A23 mRNA CTD PMID:21420995 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of SLC22A23 mRNA CTD PMID:32680482 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of SLC22A23 mRNA CTD PMID:31324951 phenylmercury acetate increases expression ISO RGD:1347503 6480464 Phenylmercuric Acetate results in increased expression of SLC22A23 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1347503 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC22A23 mRNA CTD PMID:27188386 pirinixic acid affects expression ISO RGD:1621497 6480464 pirinixic acid affects the expression of SLC22A23 mRNA CTD PMID:23811191 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1347503 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of SLC22A23 mRNA] CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1347503 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC22A23 mRNA CTD PMID:27188386 silver atom increases expression ISO RGD:1621497 6480464 Silver results in increased expression of SLC22A23 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1621497 6480464 Silver results in increased expression of SLC22A23 mRNA CTD PMID:27131904 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of SLC22A23 mRNA CTD PMID:22110744 sulforaphane increases expression ISO RGD:1347503 6480464 sulforaphane results in increased expression of SLC22A23 mRNA CTD PMID:31838189 sulpiride multiple interactions ISO RGD:1347503 6480464 Sulpiride inhibits the reaction [SLC22A23 protein results in increased uptake of 1-Methyl-4-phenylpyridinium analog] CTD PMID:28597291 sunitinib increases expression ISO RGD:1347503 6480464 Sunitinib results in increased expression of SLC22A23 mRNA CTD PMID:31533062 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of SLC22A23 mRNA CTD PMID:21515302 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC22A23 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC22A23 mRNA] CTD PMID:31150632 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLC22A23 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1621497 6480464 titanium dioxide results in increased expression of SLC22A23 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC22A23 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of SLC22A23 mRNA CTD PMID:25729387 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC22A23 mRNA CTD PMID:33387578 triptonide decreases expression ISO RGD:1621497 6480464 triptonide results in decreased expression of SLC22A23 mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:1621497 6480464 troglitazone results in decreased expression of SLC22A23 mRNA CTD PMID:28973697 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of SLC22A23 mRNA CTD PMID:21515302 valproic acid decreases methylation ISO RGD:1347503 6480464 Valproic Acid results in decreased methylation of SLC22A23 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1347503 6480464 Valproic Acid results in increased expression of SLC22A23 mRNA CTD PMID:24935251 , PMID:27188386 vincristine increases expression ISO RGD:1347503 6480464 Vincristine results in increased expression of SLC22A23 mRNA CTD PMID:23649840 zidovudine multiple interactions ISO RGD:1347503 6480464 [Zidovudine co-treated with IFNA1 protein] results in increased expression of SLC22A23 mRNA CTD PMID:20370541 zoledronic acid increases expression ISO RGD:1347503 6480464 zoledronic acid results in increased expression of SLC22A23 mRNA CTD PMID:24714768